GlaxoSmithKline S.A.E reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was EGP 539.66 million compared to EGP 346.6 million a year ago. Net income was EGP 5.76 million compared to EGP 2.64 million a year ago. Basic earnings per share was EGP 0.07 compared to EGP 0.03 a year ago.
For the six months, sales was EGP 1,000.31 million compared to EGP 716.78 million a year ago. Net income was EGP 19.57 million compared to EGP 871.81 million a year ago. Basic earnings per share was EGP 0.23 compared to EGP 10.44 a year ago.